VIVS Financials | Key Metrics & Investor Analysis
The financial statements for VIVS (VIVS) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| CYCN Cyclerion Therapeutics, Inc. | $3.03 -5.90% |
| RADX Radiopharm Theranostics Limited | $4.55 -1.13% |
| TCRT Alaunos Therapeutics, Inc. | $2.89 -3.34% |
| PLRZ Polyrizon Ltd. | $10.86 -3.98% |
| V Visa Inc. | $315.91 +1.46% |
| XTLB XTL Biopharmaceuticals Ltd. | $2.38 -2.66% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| CYCN Cyclerion Therapeutics, Inc. | $3.03 | -5.90% | 13.12 M | -2.73 | -1.11 | 0.00% | Buy | 180 |
| RADX Radiopharm Theranostics Limited | $4.55 | -1.13% | 5.86 M | -1.22 | -3.74 | 0.00% | Buy | 11 |
| TCRT Alaunos Therapeutics, Inc. | $2.89 | -3.34% | 6.87 M | -1.31 | -2.20 | 0.00% | Hold | 22 |
| PLRZ Polyrizon Ltd. | $10.86 | -3.98% | 12.17 M | -2.22 | -4.90 | 0.00% | — | 32 |
| V Visa Inc. | $315.91 | +1.46% | 609.09 B | 29.66 | 10.65 | 0.80% | Buy | 4.82 |
| XTLB XTL Biopharmaceuticals Ltd. | $2.38 | -2.66% | 810604 | -0.66 | -3.60 | 0.00% | Hold | 6 |
Frequently Asked Questions
What are VIVS's latest financial results?
Review VIVS's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has VIVS's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is VIVS's cash flow situation and liquidity?
Cash flow statements reveal how VIVS generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does VIVS's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether VIVS is outperforming or lagging within its sector.
Are VIVS's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether VIVS's profits are repeatable and supported by strong fundamentals.